UAB researchers have identified Tomosyn 2 as a key protein that balances insulin secretion and pancreatic beta cell growth, ...
Interim analysis demonstrated a 55.0% relative reduction in proteinuria versus placebo at 39 weeks with eGFR remaining stable ...
HTX-001 is a first-in-class antisense oligonucleotide designed to downregulate WISPER lncRNA, a driver of fibrosis in the heartPhase 1a/b trial to evaluate the safety and tolerability of HTX-001 in ...
In preclinical studies of CSU, Bexobrutideg demonstrates potent BTK degradation across key immune cell types and enhanced suppression of FcĪµRI-driven pathology versus remibrutinib ...
Glyn Dawson, an expert on lipid biochemistry and longtime professor in the Departments of Pediatrics and Biochemistry and ...
Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research ...
Data from Phase 2a study of LAM-001 on top of standard of care in PH-ILD patients with refractory PH demonstrated clinically meaningful ...
A massive single-cell study has revealed hidden genetic differences in male and female immune systems that may shape disease ...
A deficiency in B12 can lead to anemia, fatigue, memory issues, and neurological problems. If you are considering taking ...
Immune cell therapies have transformed the treatment of certain blood cancers over the past decade. However, when it comes to ...
Detailed price information for Fibrobiologics Inc (FBLG-Q) from The Globe and Mail including charting and trades.
Abbott, the global healthcare company, today announced the launch of Ensure® Strength Pro, a scientifically designed blend of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results